Stockreport

*Acorda Therapeutics upgraded to Overweight from Neutral at Piper Jaffray

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors